<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2020.103012</article-id><article-id pub-id-type="publisher-id">JCDSA-102544</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Effective Treatment of Acne Fulminans with Oral Corticosteroids
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ichiro</surname><given-names>Kurokawa</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Dermatology, Meiwa Hospital, Nishinomiya, Japan</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>07</month><year>2020</year></pub-date><volume>10</volume><issue>03</issue><fpage>107</fpage><lpage>109</lpage><history><date date-type="received"><day>18,</day>	<month>June</month>	<year>2020</year></date><date date-type="rev-recd"><day>25,</day>	<month>August</month>	<year>2020</year>	</date><date date-type="accepted"><day>28,</day>	<month>August</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  An 18-year-old man had numerous multiple painful nodulocystic lesions, pustules, and necrotic hemorrhagic ulcerative lesions with crusts on the face, back, chest and upper arm two weeks ago. Systemic symptoms such as fever, general fatigue and arthralgia were not observed. Laboratory findings revealed an elevated white blood cell count with a neutrophilia and C-reactive protein. Oral antimicrobials did not respond. Consequently, oral prednisolone (20 mg/d) for two weeks induced remarkable improvement promptly. A case of acne fulminans without systemic symptoms successfully treated with oral corticosteroids has been reported.
 
</p></abstract><kwd-group><kwd>Acne Fulminans</kwd><kwd> Treatment</kwd><kwd> Systemic Symptoms</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Case Report</title><p>An 18-year-old man had inflammatory acne lesions on the face, back and upper arm two years ago. He was treated with oral cefdinir, topical antimicrobials and benzoyl peroxide (BPO) two years ago. However, the lesions did not respond to these treatments.</p><p>Numerous multiple painful nodulocystic lesions, pustules, and necrotic hemorrhagic ulcerative lesions with crusts developed the face, back, chest and upper arm two weeks ago. Systemic symptoms such as fever, general fatigue and arthralgia were not observed. Movement restriction caused by pain was observed in the shoulder joint. He was diagnosed as acne fulminans (AF). Laboratory findings revealed an elevated white blood cell (WBC) count (20,300/μl) (normal level: 4000 - 9000/μl) with a neutrophilia and C-reactive protein (CRP) (3.91 mg/dl) (normal level: below 0.30 mg/dl). Notably, Staphylococcus epidermidis was detected in the bacterial culture from the lesion.</p><p>Initially, the patient was treated with oral faropenem 600 mg/d and Saireito 8.1 g/d (Japanese Herb) for two weeks. Subsequently, he was treated with oral minocycline 100 mg/d. The lesions did not respond to these treatments and rather developed into a hemorrhagic ulcer (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)). Consequently, he was treated with additional oral prednisolone (20 mg/d) for two weeks. The lesions showed remarkable improvement promptly. The hemorrhagic ulcerations were re-epithelialized, resulting in postinflammatory hyperpigmentation (<xref ref-type="fig" rid="fig1">Figure 1</xref>(b)). In addition, the pain subsided quickly, and movement restriction in the shoulder joint was improved.</p><p>The informed consent was obtained from the patient to reproduce the clinical findings.</p></sec><sec id="s2"><title>2. Discussion</title><p>AF is usually defined as a sudden onset severe ulcerative acne with toxic effects such as fever, weight loss and arthralgia. It fails to respond to antimicrobial therapy and shows favorable responses to debridement in combination with steroid therapy [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102544-ref2">2</xref>]. AF is exclusively observed in adolescents of age ranging from 13 - 16 years [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102544-ref2">2</xref>]. Notably, this condition is more frequently observed in males than in females [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102544-ref2">2</xref>], and its clinical manifestation includes hemorrhagic ulcerations with pain [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102544-ref2">2</xref>]. AF without systemic symptoms and abnormal laboratory findings were reported as AF “sine fulminans” [<xref ref-type="bibr" rid="scirp.102544-ref3">3</xref>]. In our case, a sudden onset was observed with painful hemorrhagic necrotic ulcers with crusts. Additionally, increased WBC count with neutrophilia and elevated CRP were observed. In spite of unresponsiveness by antimicrobial therapy, the lesions responded to corticosteroid therapy. In view of the above-mentioned findings, our patient was diagnosed with AF.</p><p>The etiology of AF is unclear. The immunological response to Cutibacterium acnes (C. acnes), neutrophil function, hypersensitive responses to either sebum or bacterial antigens, and genetic factors might be responsible [<xref ref-type="bibr" rid="scirp.102544-ref4">4</xref>].</p><p>As differential diagnosis, acne conglobata (AC) is considered. AC is usually observed in adults [<xref ref-type="bibr" rid="scirp.102544-ref4">4</xref>]. The clinical manifestations of AC mainly include nodules, cysts, and polyporus comedones [<xref ref-type="bibr" rid="scirp.102544-ref4">4</xref>].</p><p>Concerning therapy for AF, a combination therapy with corticosteroids and isotretinoin is highly recommended [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>]. However, the use of isotretinoin is not allowed in Japan. Isotretinoin may precipitate AF as it promotes fragility of the sebaceous duct, resulting in significant contact with C. acnes [<xref ref-type="bibr" rid="scirp.102544-ref1">1</xref>].</p><p>The long-term prognosis of AF after the treatment is good without recurrence.</p></sec><sec id="s3"><title>3. Conclusion</title><p>A case of acne fulminans without systemic symptom successfully treated with oral corticosteroids has been reported.</p></sec><sec id="s4"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s5"><title>Cite this paper</title><p>Kurokawa, I. (2020) Effective Treatment of Acne Fulminans with Oral Corticosteroids. Journal of Cosmetics, Dermatological Sciences and Applications, 10, 107-109. https://doi.org/10.4236/jcdsa.2020.103012</p></sec></body><back><ref-list><title>References</title><ref id="scirp.102544-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Plewig, G. and Kligman, A.M. (2005) Acne Fulminans. In: ACNE &amp; ROSACEA, 3rd Edition, Springer-Verlag, Berlin, 342-351 https://doi.org/10.1007/978-3-642-59715-2_24</mixed-citation></ref><ref id="scirp.102544-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Cunliffe, W.J. (1989) Acne Fulminans. In: ACNE, Martin Dunitz, London, 33-36.</mixed-citation></ref><ref id="scirp.102544-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Thomson, K.F. and Cunliffe, W.J. (2000) Acne Fulminans ‘Sine Fulminans’. Clinical and Experimental Dermatology, 25, 299-301. https://doi.org/10.1046/j.1365-2230.2000.00647.x</mixed-citation></ref><ref id="scirp.102544-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Katsambas, A.D., Dessinioti, C. and Cunliffe, W.J. (2014) Clinical Aspects of Acne Fulminans. In: Pathogenesis of Acne and Rosacea, Springer, Berlin, 223-226. https://doi.org/10.1007/978-3-540-69375-8_29</mixed-citation></ref></ref-list></back></article>